Jacobs Levy Equity Management’s Tabula Rasa HealthCare TRHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-72,163
Closed -$744K – 1108
2023
Q3
$744K Sell
72,163
-40,460
-36% -$384K ﹤0.01% 726
2023
Q2
$929K Sell
112,623
-119,029
-51% -$712K 0.01% 707
2023
Q1
$1.29M Sell
231,652
-246,505
-52% -$1.41M 0.01% 652
2022
Q4
$2.37M Sell
478,157
-148,653
-24% -$612K 0.02% 522
2022
Q3
$3.01M Buy
626,810
+452,154
+259% +$1.94M 0.02% 481
2022
Q2
$449K Sell
174,656
-4,422
-2% -$16.6K ﹤0.01% 884
2022
Q1
$1.03M Buy
+179,078
New +$1.61M 0.01% 749

Other funds holding TRHC

Jacobs Levy Equity Management's TRHC Position: Q4 2023 in Review

Jacobs Levy Equity Management sold out of Tabula Rasa HealthCare (TRHC) in Q4 2023, closing a stake of 72,163 shares — an estimated $744K sold.

Jacobs Levy Equity Management first reported a position in TRHC in Q1 2022 and held it in 7 quarters. The position peaked at $3.01M in Q3 2022. 1 fund tracked by Wall St. Rank holds TRHC as of Q4 2023.

  • Jacobs Levy Equity Management reported no remaining Tabula Rasa HealthCare position as of Q4 2023 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 72,163 Tabula Rasa HealthCare shares in Q4 2023, an estimated $744K.
  • Jacobs Levy Equity Management first reported a position in Tabula Rasa HealthCare in Q1 2022 and held it in 7 quarters.
  • Jacobs Levy Equity Management's Tabula Rasa HealthCare position peaked at $3.01M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Tabula Rasa HealthCare as of Q4 2023.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2023, filed 14 Feb 2024.